| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.088 | 0.003 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | 0.13 | 0.003 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.15 | 0.003 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.096 | 0.004 |